Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Bladder cancer
by Highest Patent Value in the Japan in 2019

The Bladder cancer top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Bladder cancer Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
#
Company Name
Region
Tech Topics
Total
1
Clinical trial,Cardiovascular agent,Drug,
...[+2]
Avg patent value: 9.48 M
2
Medicine,Health care,Clinical trial,
...[+2]
Avg patent value: 6.96 M
3
Avg patent value: 6.96 M
4
Diagnostic Reagent,Medicine,Health care,
...[+2]
Avg patent value: 6.02 M
5
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 4.49 M
6
Drug,Clinical trial,Health care,
...[+2]
Avg patent value: 4.35 M
7
Avg patent value: 4.11 M
8
Avg patent value: 3.61 M
9
Fiber,Textile,Textile (markup language),
...[+2]
Avg patent value: 3.06 M
10
Avg patent value: 2.63 M
11
Avg patent value: 2.34 M
12
Avg patent value: 1.48 M
13
Avg patent value: 196,666
14
Avg patent value: 130,000
15
Avg patent value: 13,000
16
Avg patent value: 3,500
17
Avg patent value: 0
18
Medical imaging,Attractiveness,Product group,
...[+2]
Avg patent value: 0
19
Avg patent value: 0
20
Avg patent value: 0
Page generation time: May 12 2025